DOC logo

Healthpeak Properties (DOC)

$19.46

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on DOC

Market cap

$13.42B

EPS

0.54

P/E ratio

53.7

Price to sales

4.39

Dividend yield

6.269%

Beta

1.013003

Price on DOC

Previous close

$19.84

Today's open

$19.68

Day's range

$19.29 - $19.84

52 week range

$15.70 - $22.95

Profile about DOC

CEO

Scott M. Brinker

Employees

411

Headquarters

Denver, CO

Exchange

New York Stock Exchange

Shares outstanding

689543752

Issue type

Common Stock

DOC industries and sectors

Real Estate

REITs

News on DOC

Healthpeak Properties' Scavenger Mentality

Healthpeak Properties is undervalued, with 33% upside to fair value and a $27/share target. DOC's opportunistic life science acquisitions at distressed prices are positioned to double in value within 7 years. The JAN spinoff enabled DOC to capitalize on senior housing at high cap rates, locking in forward growth and AFFO accretion.

news source

Seeking Alpha • Nov 12, 2026

news preview

Doctors' Offices, Labs and Nursing Homes Pay Rent to These 3 REITs, and $150,000 Yields $8,510 a Year

Every clinic visit, rehab stay, and lab experiment ends with a rent check, and three healthcare landlords collect it. One has already cut its dividend twice, and another leans on Medicare dollars.

news source

24/7 Wall Street • Nov 9, 2026

news preview

November Buy: 6 IDEAL S&P 500 'Safer' Dividend Dogs

Six S&P 500 'safer' high-yield dividend stocks—Regions Financial, Ford, AT&T, Pfizer, Verizon, VICI Properties—currently offer attractive buy signals based on free cash flow yields. Analyst projections for the top ten S&P 500 dividend dogs indicate potential net gains of 14.54% to 40.07% by November 2027, with an average estimated gain of 27.42%. Dividend dog strategy favors stocks where annual dividends from $1,000 invested exceed single-share prices and free cash flow yields surpass dividend yields.

news source

Seeking Alpha • Nov 6, 2026

news preview

What Healthpeak Properties (DOC) Said on Its Q3 Earnings Call

Healthpeak Properties NYSE: DOC raised its full-year earnings outlook for the third time in 2026 after reporting what President and Chief Executive Officer Scott Brinker described as a strong operational quarter across outpatient medical, life science and senior housing.

news source

MarketBeat • Nov 4, 2026

news preview

Healthpeak Properties: Potential Life Science Rebound Creates A Strong Re-Rating Setup

Healthpeak Properties is reiterated as a Buy, driven by resilient earnings, another guidance boost, and a compelling valuation offering a good margin of safety. DOC's Lab segment shows signs of stabilization and potential rebound, supported by strong occupancy gains and positive leasing momentum. Outpatient Medical and Senior Housing segments deliver robust growth, with Senior Housing posting a 25.9% NOI increase amid very strong performance from Janus Living.

news source

Seeking Alpha • Nov 4, 2026

news preview

Healthpeak Properties: FFO Is Down, But The Best Is Yet To Come

Healthpeak Properties is a 5% portfolio position, driven by a bullish multi-year Life Science turnaround thesis and acquisition-led growth potential. Q3 2026 guidance was revised upward, with the FFO midpoint now $1.77 and the FFO payout ratio improving to 69%, reflecting operational resilience. Lab segment occupancy increased 130 bps sequentially, with year-over-year same-store NOI trending toward positive territory, supporting future AFFO growth.

news source

Seeking Alpha • Nov 4, 2026

news preview

Healthpeak Properties, Inc. (DOC) Q3 2026 Earnings Call Transcript

Healthpeak Properties, Inc. ( DOC ) Q3 2026 Earnings Call November 3, 2026 10:00 AM EST Company Participants Andrew Johns - Senior Vice President of Investor Relations Scott Brinker - President, CEO & Director Kelvin Moses - Chief Financial Officer Scott Bohn - Chief Development Officer & Head of Lab Conference Call Participants Richard Anderson - Cantor Fitzgerald & Co., Research Division Michael Carroll - RBC Capital Markets, Research Division James Feldman - Wells Fargo Securities, LLC, Research Division Ronald Kamdem - Morgan Stanley, Research Division Nicholas Yulico - Scotiabank Global Banking and Markets, Research Division Juan Sanabria - BMO Capital Markets Equity Research Sydney McEntee - JPMorgan Chase & Co, Research Division Michael Goldsmith - UBS Investment Bank, Research Division Farrell Granath - BofA Securities, Research Division Nicholas Joseph - Citigroup Inc., Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division David Rodgers - Raymond James & Associates, Inc., Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division James Kammert - Evercore ISI Institutional Equities, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good morning, and welcome to the Healthpeak Properties, Inc. Third Quarter 2026 Conference Call. [Operator Instructions] Please note, this event is being recorded.

news source

Seeking Alpha • Nov 3, 2026

news preview

Healthpeak's Q3 FFOA Beat Estimates on Leasing, Senior Housing Growth

DOC's Q3 2026 FFOA and revenues beat estimates, driven by solid outpatient leasing and senior housing growth, prompting an upgraded full-year FFOA outlook.

news source

Zacks Investment Research • Nov 3, 2026

news preview

Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the quarter ended September 30, 2026. THIRD QUARTER 2026 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.02 per share and FFO as Adjusted of $0.44 per share Outpatient Medical new and renewal lease executions totaled 846,000 square feet, bringing year-to-date Outpatient Medical lea.

news source

Business Wire • Nov 2, 2026

news preview

Healthpeak (DOC) Q3 FFO and Revenues Surpass Estimates

Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to FFO of $0.46 per share a year ago.

news source

Zacks Investment Research • Nov 2, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Healthpeak Properties

Open an M1 investment account to buy and sell Healthpeak Properties commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in DOC on M1